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Edited by Veli-Pekka LehtoAbstract CD14, CD68 and/or mouse F4/80 or human epidermal
growth factor module-containing mucin-like receptor 1 (EMR1)
are widely used as macrophage-speciﬁc markers. Since macro-
phages inﬁltrate several tissues during inﬂammatory processes,
CD14, CD68 and EMR1-F4/80 have been employed to discrimi-
nate between tissue-containing macrophages, like adipose tissue
(AT), and other cells. Using real-time PCR experiments, we show
that isolated adipocytes from humans and mice AT express high
levels of CD14 and CD68 mRNA, whereas EMR1-F4/80 is
mainly present in the macrophage-containing stroma-vascular
fraction. Furthermore, ﬁbroblasts-like cells (adipoblasts), preadi-
pocytes and adipocytes from the murine cell lines, 3T3-F442A
and BFC-1, express CD14 and CD68 mRNA and protein as
determined by ﬂuorescence-activated cell sorter, but not F4/80
which, as expected, is strongly expressed in the macrophage cell
line RAW264.7. These results reinforce the view that EMR1-F4/
80 is the best macrophage marker to date and show that CD14
and CD68 are not macrophage-speciﬁc proteins.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The lipopolysaccharide-binding protein CD14, the macros-
ialin CD68 and the G protein-linked TM7-homologous
receptor from humans (epidermal growth factor module-con-
taining mucin-like receptor 1; EMR1) or mouse (F4/80) are
widely used macrophage markers [1,2]. CD14 binds LPS,
interacts with Toll-like receptor 4 (TLR4), thereby inducing
cytokine production and mediating phagocytic clearance of
apoptotic cells [3,4]. CD68 is a member of the lysosomal-
associated membrane protein family [5]. EMR1-F4/80 isAbbreviations: EMR1, epidermal growth factor module-containing
mucin-like receptor 1; AT, adipose tissue; TLR, toll-like receptor;
MCP-1, monocyte chemoattractant protein-1; SVF, stroma-vascular
fraction of cells; MIF, macrophage migration inhibitory factor; FACS,
ﬂuorescence-activated cell sorter; GAPDH, glyceraldehyde-3P dehy-
drogenase
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doi:10.1016/j.febslet.2005.09.032homologous to the secretin family of proteins [2]. Since mac-
rophages inﬁltrate several tissues during inﬂammatory pro-
cesses, CD14, CD68 and EMR1-F4/80 have been employed
to discriminate between tissue-containing macrophages and
other cells [6,7]. Among these tissues, adipose tissue (AT)
was recently the focus of extensive investigation. The pres-
ence of macrophages in AT was documented [6,8]. In addi-
tion, obesity and the development of obesity-related insulin
resistance were correlated with increased macrophage accu-
mulation and inﬂammatory activities [7,9,10]. In all these
studies, CD14, CD68 and/or F4/80 were used as macrophage
discriminative markers. However, a role for preadipocytes as
macrophage-like cells was reported, showing the plasticity of
such cells [11]. Besides, AT from various depots displayed
diﬀerential macrophage functions such as phagocytic and
microbicidal activities [12]. Furthermore, in vitro diﬀerenti-
ated adipocytes were shown to express innate immunity fac-
tors, like TLR2 and TLR4 [13]. These observations
prompted us to identify which of the previously character-
ized macrophage-selective markers could be expressed in
other cell types like ﬁbroblasts, preadipocytes or adipocytes
and which one would be speciﬁc.2. Materials and methods
2.1. Animals
Animal studies were conducted according to the French Guidelines
for the Care and Use of Experimental Animals. Sixteen weeks old
Balb/c male mice (Elevage Janvier, Bagneux) were killed by decapita-
tion at 10:00 a.m. then omental (OM) and subcutaneous (SC) WAT
were removed for analyses.2.2. Isolation of adipocytes and stroma-vascular cells from adipose tissue
Explants of SC AT were obtained from three healthy women under-
going plastic surgery. They were aged 49, 46 or 37 and had body mass
index of 26.5 ± 0.7 kg/m2. None of the subjects suﬀered from known
metabolic or malignant diseases nor were they taking medications
known to alter AT metabolism. All the patients gave informed written
consent. The study was carried out according to the tenets of the Hel-
sinky protocol.
SC and OM AT were isolated from mice as described in Weisberg
et al. [6]. Once digestion was complete, samples were passed through
a sterile 250-lm nylon mesh (Sefar AG, Switzerland), then centrifuged
at 1000 · g for 8 min. The adipocyte-enriched ﬂoating fraction was
further digested for 1 h with liberase 3 (Roche Applied Science),ation of European Biochemical Societies.
Fig. 1. Expression of CD14, CD68 and EMR1-F4/80 mRNAs in
mouse and human AT, adipocytes and stroma-vascular cells. (A)
Mouse RNA was isolated from SC and OM AT, as well as from ADIP
and SVF cells from mice obtained following two successive treatments
with liberase 3 as described in Section 2, the ﬁnal centrifugation
leading to an adipocyte-enriched fraction (ADIP) and a pelleted
macrophage-enriched fraction (SVF). CD14, CD68 and F4/80 mRNA
concentrations were evaluated by real time RT-PCR. Results are
expressed in % mRNA relative to SC AT taken as 100% for each
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rogen Corp.), and centrifuged at 1000 · g for 8 mins. The supernatant
(adipocytes) was placed in Qiazol lysis reagent (Qiagen) and kept at
80 C for later RNA extraction. The macrophage-enriched pelleted
fractions of the stroma-vascular cells (SVFs) was resuspended in
acid-phenol reagent (TRIzol; Invitrogen Corp., Cergy-Pontoise) and
kept at 80 C for later RNA extraction. The same procedure was ap-
plied to human adipose tissue.
2.3. RNA extraction and analysis
Total RNA was extracted from 3T3-F442A [14] and BFC-1 [15]
cells, grown and diﬀerentiated as described [16], using TRIzol. For tis-
sue samples (100 mg), extraction was carried out by RNeasy Mini Kit
(Qiagene, Courtaboeuf). RNA was quantiﬁed by spectrophotometric
Nanodrop (ND-1000) (NYXOR BIOTECH), and the quality was as-
sessed by gel electrophoresis.
The ﬁrst-strand cDNA was synthesized using High Capacity cDNA
Archive (Applied Biosystems, Courtaboeuf) using 500 ng of RNA.
Samples of cDNA were diluted 1:2 in nuclease-free water. PCR ampli-
ﬁcation mixtures (10 ll) contained 5 ll of Absolute SYBR Green Rox
Mix (AB gene), 0.3 ll of a mixture of 10 lM reverse and forward prim-
ers, 3.4 ll nuclease-free water and 1 ll diluted cDNA template. Quan-
titative RT-PCR measurements were performed on an ABI Prism
7900 Sequence Detector system with SDS 2.1 Software (Applied Bio-
systems). PCR cycles proceeded as follows: Taq activation (10 min,
95 C), then 40 cycles of denaturation (15 s, 95 C), annealing (30 s,
60 C) and extension (30 s, 72 C). The melting-curve analysis showed
the speciﬁcity of the ampliﬁcations. Threshold cycle, which inversely
correlates with the target mRNA level, was measured as the cycle
number at which the reporter ﬂuorescent emission appears above the
background threshold. The relative mRNA levels were estimated by
the standard method using glyceraldehydes-3-phosphate dehydroge-
nase (GAPDH) as the reference gene.
Primer sequences were as follows (forward-reverse):
Human:
hGAPDH (5 0-AACAGCCTCAAGATCAGCAA-3 0)–(5 0-CAGTCT-
GGGTGGCAGTGAT-30),
hCD68 (5 0-GAACCCCAACAAAACCAAG-30)–(5 0-GATGAGAG-
GCAGCAAGATG-3 0),
hCD14 (5 0-TCTCTGTCCCCACAAGTTCC-3 0)–(5 0-CCCGTCCA-
GTGTCAGGTTATC-3 0),
EMR1 (5 0-CCAAGGGGGATAAGATGAAG-30)–(5 0-CACCAAGG-
AGATGATTAATGCC-30),
Mouse:
F4/80 (5 0-TTTCCTCGCCTGCTTCTTC-30)–(5 0-CCCCGTCTCTG-
TATTCAACC-3 0),
CD68 (5 0-AGGGTGGAAGAAAGGTAAAGC-3 0)–(5 0-AGAGCA-
GGTCAAGGTGAACAG-3 0),
CD14 (5 0-GGCTTGTTGCTGTTGCTTC-30)–(5 0-CAGGGCTCCG-
AATAGAATCC-3 0),
GAPDH (5 0-AACGACCCCTTCATTGAC-3 0)–(5 0-TCCACGACA-
TACTCAGCAC-3 0).
2.4. Flow cytometry and immunocytochemistry
Assessment of mouse adipocyte (3T3-F442A, BFC-1) and macro-
phage (RAW264.7) cell lines was performed with Alexa 488-conju-
gated CD14 antibody (Caltag laboratories, Burlingame), or Alexa
647-conjugated CD68 antibody (Serotec, Cergy Saint-Christophe)
and rat anti-F4/80 plus FITC-conjugated secondary antibodies
(Jackson immunoResearch, Cambridgeshire). Non-speciﬁc binding
was controlled with speciﬁc isotype antibodies, mouse Alexa 488-
conjugated IgG1 and rat Alexa 647-conjugated IgG2a (Caltag labo-
ratories, Burlingame). Cell suspensions were analyzed on an Epics
Elite-ESP ﬂow cytometer (Beckman-Coulter, France). The same la-
belled cells were mounted and used for microscopic observation
using a confocal Zeiss LSM510 microscope. Each experiment was
repeated at least twice.marker. Relative expression of each marker to the GAPDH control
gene expression in SC AT are: 1.1% for CD14, 0.2% for CD68 and
0.84% for F4/80. (B) Human RNA isolation and analysis are identical
to those for mice except that in this case, only SC AT has been studied.
Relative expression of each marker to the GAPDH control gene
expression are : 3.4% for CD14, 3.9% for CD68 and 0.5% for EMR1-
F4/80. Mean ± S.E.M. from three separate experiments is shown.3. Results and discussion
We used quantitative RT-PCR experiments to study the le-
vel of expression of CD14, CD68 and EMR1-F4/80 genes intotal and subfractionated AT isolated from a SC localization
in mice and humans and from a profound depot in mice, the
OM AT, the metabolism of which is known to be diﬀerent
from that of SC [17]. For subfractionation, two consecutive
collagenase digestions were carried out to separate the pelleted
SVF of cells from ﬂoating adipocytes. In mice, CD14, CD68
and F4/80 mRNA were detected at higher levels in OM than
in SC (Fig. 1A). As expected, SVF from both AT localization
expressed the three markers at similar high levels, most prob-
ably detecting macrophages in this fraction (Fig. 1A). The level
of CD14 and CD68 mRNAs in the adipocyte fraction was
close to that observed in AT. This could be due to the presence
of remaining macrophages in the adipocyte fraction or to bona
ﬁde expression of CD14 and CD68 in adipocytes. The situation
is quite diﬀerent with F4/80 transcript which was drastically re-
duced in SC and OM adipocytes compared to the respective
AT (Fig. 1A). This result strongly suggested that the propor-
tion of remaining resident macrophages in the adipocyte frac-
tion was low and that adipocytes per se expressed CD14 and
CD68 but not F4/80. A similar situation occurred in human
SC AT, in which CD14 and CD68 but not EMR1-F4/80
mRNAs were strongly expressed in isolated adipocytes
(Fig. 1B). Others have shown a higher expression of CD68 in
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80 is macrophage-speciﬁc, we found that in rodent SC, adipo-
cyte CD14 and CD68 mRNAs correspond, respectively, to
11.1% and 10.8% of those mRNAs in the macrophage-contain-
ing SVF of cells. The same calculation for OM AT gives 9.1%
and 16.2%. In human SC adipocytes, the percentages found
were much higher than in rodent SC adipocytes, i.e. 35.4%
and 62.2% for CD14 and CD68, respectively.
SVF contains macrophages plus other cell types, for instance
ﬁbroblasts and preadipocytes. To discriminate between these
cell types, we decided to use two distinct model cell systems
of ﬁbroblasts-like cells (adipoblast) diﬀerentiation into adipo-
cytes, the 3T3-F442A and the BFC-1 mouse cell lines. As
shown in Fig. 2A, CD14 and CD68 mRNAs (but not F4/80,
data not shown), were present in both cell lines throughout dif-
ferentiation, demonstrating that ﬁbroblast-like cells (adipo-Fig. 2. Expression of CD14, CD68 and F4/80 in 3T3-F442A, BFC-1 and RA
various days relative to conﬂuence (day 0). CD14 and CD68 mRNA concentra
% mRNA relative to CD68 mRNA taken as 100% at conﬂuence. Relative exp
are: 1.1% for 3T3-F442A and 0.4% for BFC-1. Mean ± S.E.M. from three sep
of 3T3-F442A, BFC-1 and RAW264.7 cells using speciﬁc CD14, CD68 or F
membrane-labelled CD14 (green) and CD68 (red) for 3T3-F442A and BFC-blasts, 2 days before conﬂuence; day 2), preadipocytes
(conﬂuence; day 0) and adipocytes (day 13), all expressed
CD14 and CD68 transcripts, although at various levels, with
a peak at day 0 and day 2. Like in mice AT in vivo, CD14
mRNA was present at higher concentration than CD68
(Fig. 2A). We chose cells at day 2 to evaluate the presence of
CD14, CD68 and F4/80 by ﬂuorescence-activated cell sorter
(FACS). Fig. 2B shows that about 25% of 3T3-F442A and
BFC-1 cells expressed both CDs. As expected from the RT-
PCR studies, F4/80 was absent from both lines. The highly po-
sitive RAW264.7 cells, a control macrophage cell line from
mice, showed antibody speciﬁcity for the three markers. F4/
80 was present in RAW264.7 only. Immunoﬂuorescence stud-
ies with the same antibodies as those used for FACS pointed
out the presence of CD14 and CD68 at the cell surface of both
lines (Fig. 2B, inset).W264.7. (A) RNA was isolated from 3T3-F442A and BFC-1 cells at
tions were evaluated by quantitative RT-PCR. Results are expressed in
ression of CD68 to the GAPDH control gene expression at conﬂuence
arate experiments is shown. (B) Representative ﬂow cytometry analysis
4/80 antibody as described in Section 2. Insert: photomicrographs of
1.
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three expected macrophage-speciﬁc markers, only EMR1-F4/
80 shows a strict speciﬁcity. The observation that EMR1-F4/
80 is neither expressed in human and murine adipocytes nor
in 3T3-F442A and BFC-1 cells at diﬀerent development stages
(ﬁbroblasts, preadipocytes and adipocytes) makes us consider
this protein as the best macrophage marker. Both CD14 and
CD68 are expressed in ﬁbroblasts-like cells (adipoblasts), pre-
adipocytes and adipocytes in addition to macrophages. Recent
studies have shown that CD68 antibodies overlap in speciﬁcity
with ﬁbroblasts [19]. This observation reinforces our demon-
stration that CD14 and CD68 are not macrophage-speciﬁc
markers. AT is an important mediator of inﬂammation and in-
nate immunity [20,21]. Various AT depots display diﬀerential
phagocytic and microbicidal activities depending on their local-
ization [12] and preadipocytes have the potential to be con-
verted into macrophages [22]. We demonstrate here that
adipocytes also present macrophage-like characters. Other
studies show the presence of MCPI in human adipose tissue
[18,23] and expression of the macrophage migration inhibitory
factor (MIF) in murine adipose tissue [8] and 3T3-L1 cell line
[24]. Additionally, markers, originally described as adipocyte-
speciﬁc, are present in macrophages [25,26]. The role of
CD14 and CD68 in the adipocyte diﬀerentiation process re-
mains an opened issue to be addressed.
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